These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7000791)

  • 1. Immunological enhancement induced by gastrointestinal immunization of mice pretreated with cyclophosphamide.
    Laursen ML
    J Cancer Res Clin Oncol; 1980; 96(3):231-41. PubMed ID: 7000791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of salicyl-azo-sulfapyridine on the immune response to antigenic tumour cells inoculated into the coecal lumen of C3H mice.
    Laursen ML
    Scand J Gastroenterol; 1978; 13(8):991-7. PubMed ID: 31676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization by the intestinal route of C3H-mice against C3H-L-ascites tumor cells.
    Laursen ML; Laursen K
    Proc Soc Exp Biol Med; 1977 Feb; 154(2):314-7. PubMed ID: 840870
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfer of immunity by transfer of bone marrow cells: a requirement for T lymphocytes and sensitivity to cyclophosphamide.
    Marusić M
    Exp Hematol; 1978 Oct; 6(9):725-37. PubMed ID: 361429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of tumour growth in two syngeneic C3H murine systems by immunization via the intracaecal route.
    Laursen ML; Laursen K
    Br J Cancer; 1978 Jun; 37(6):1039-45. PubMed ID: 678425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dependence on antigen dose and timing in the immune response of C3H mice to malignant ascites cells.
    Laursen ML; Laursen K
    Immunology; 1980 Jul; 40(3):403-10. PubMed ID: 7429535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of synergy between cyclophosphamide therapy and immunity against a mouse tumour.
    Chassoux DM; Gotch FM; MacLennan IC
    Br J Cancer; 1978 Aug; 38(2):211-8. PubMed ID: 698035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect on tumor growth and antibody production.
    Isakov N; Segal S; Hollander N; Feldman M
    Int J Cancer; 1978 Oct; 22(4):465-70. PubMed ID: 359490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of different doses of cyclophosphamide on the immune response of mice with a methylcholanthrene-induced sarcoma].
    Gordienko SP; Bergol'ts VM
    Vopr Onkol; 1973; 19(11):54-60. PubMed ID: 4785975
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
    Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
    Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
    [No Abstract]   [Full Text] [Related]  

  • 11. Serological response to intracaecal injections of antigenic mouse tumour cells.
    Laursen ML
    Br J Cancer; 1978 Dec; 38(6):692-8. PubMed ID: 369587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour sensitization obtained by injection of antigenic tumour cells into the caecal lumen of syngeneic mice.
    Laursen ML; Laursen K
    Eur J Cancer (1965); 1979 Apr; 15(4):537-42. PubMed ID: 436914
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in immune response to sheep red blood cells during growth of transplantable rat tumor.
    Gerö-Ferencz E; Medgyesi GA
    Oncology; 1982; 39(6):396-8. PubMed ID: 6890195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyclophosphamide on syngeneic transplantation of adenovirus 12-transformed tumor cells in C3H/he mice.
    Pauluzzi S; Merletti L
    Boll Ist Sieroter Milan; 1977 Sep; 56(4):310-5. PubMed ID: 20903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced immunogenicity of xenogenized tumor cells in rats pretreated with cyclophosphamide.
    Terishimna M; Takeichi N; Suzuki K; Itaya T; Gotohoda E; Kobayashi H
    Tohoku J Exp Med; 1980 Nov; 132(3):355-61. PubMed ID: 7466815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.
    Hewitt HB; Blake ER; Walder AS
    Br J Cancer; 1976 Mar; 33(3):241-59. PubMed ID: 773395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced resistance in normal mice and growth enhancement in tumor-bearing mice by inoculation with syngeneic hybrid cells.
    Dei T; Tachibana T
    J Natl Cancer Inst; 1980 Oct; 65(4):739-49. PubMed ID: 6448309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibody responses to an ascitic variant of rat hepatoma D23.
    Robins RA
    Br J Cancer; 1975 Jul; 32(1):21-7. PubMed ID: 169868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies produced by in vitro immunization with sera of human-xenotransplant-bearing mice.
    Sproll MW; Spindler E; Anderer FA
    Immunol Lett; 1988 Jan; 17(1):29-33. PubMed ID: 3280477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-tumour host cells of transplanted rat neoplasms of different immunogenicity.
    Moore K; Moore M
    Int J Cancer; 1977 Jun; 19(6):803-13. PubMed ID: 326682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.